- 专利标题： SAROGLITAZAR FOR THE TREATMENT OF HEPATOCELLULAR CARCINOMA
-
申请号： US17414733申请日： 2019-12-17
-
公开(公告)号： US20220071954A1公开(公告)日： 2022-03-10
- 发明人: Mukul R. JAIN , Suresh GIRI
- 申请人： CADILA HEALTHCARE LIMITED
- 申请人地址： IN Ahmedabad, Gujarat
- 专利权人： CADILA HEALTHCARE LIMITED
- 当前专利权人： CADILA HEALTHCARE LIMITED
- 当前专利权人地址： IN Ahmedabad, Gujarat
- 优先权： IN201821047938 20181218
- 国际申请： PCT/IB2019/060898 WO 20191217
- 主分类号： A61K31/40
- IPC分类号： A61K31/40 ; A61P35/00
摘要：
The present invention relates to pharmaceutical compositions containing the formula (I) for the prevention, delay of progression, or treatment of a disease or condition from hepatocellular carcinoma. The present invention further provides the composition of formula (I) useful in the prevention and treatment of hepatocellular carcinoma.
信息查询
